Indian drug maker Sun Pharmaceutical surged as much as 3 per cent in morning trade on BSE and NSE amid news that the company is likely to enter into a marketing tie up with US drug major Merck amp; Co.
Shares of Sun Pharma touched Rs 455.90,a jump of 3 per cent over its previous closing price on the Bombay Stock Exchange.
A similar trend was witnessed in National Stock Exchange where the scrip surged by 3 per cent to Rs 454.90 a piece.
The partnership,if announced,would be the second such large scale sales and marketing tie up between a multinational and local drug maker this year after German drug firm Bayer AG announced a joint marketing venture with Ahmedabad-based Cadila Healthcare in January.